教育提高了青少年对芬太尼尔的感知控制,但并没有提高风险识别.
Christine Bakos-Block1, Francine R Vega2, Marylou Cardenas-Turanzas1
1Center for Behavioral Emergency and Addiction Research, McWilliams School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.
Children (Basel, Switzerland)
|June 26, 2025
概括
基于学校的芬太尼教育可能会改善青少年关于物质使用的行为意图. 然而,教育并没有显著提高他们对鉴定芬太尼的信心,强调需要加强风险识别策略.
科学领域:
- 公共卫生 公共卫生
- 青少年医学 青少年医学
- 药物使用研究研究 药物使用研究
背景情况:
- 2022年,有220万名青少年被诊断患有物质使用障碍,其中265,000人患有阿片类药物使用障碍.
- 13万名青少年滥用处方止痛药,通常来自社交网络.
- 青少年认为每周使用海洛因的风险较小,与年轻或年长的年龄组相比.
研究的目的:
- 评估芬太尼宣传课程对德克萨斯州农村学区青少年的影响.
- 探索人口特征,教育干预和学生对物质使用和芬太尼的反应之间的关联.
- 评估与教育后芬太尼暴露相关的信心和行为意图的变化.
主要方法:
- 在德克萨斯州一个农村学区的7-12年级学生接受了一份问卷.
- 参与者被分为年轻人 (7-8年级) 和老年人 (9-12年级) 组.
- 奇方位和费舍尔的精确测试被用来分析人口统计,反应和教育影响之间的关联.
主要成果:
- 在接受教育和青少年感觉更能控制与物质有关的行为之间发现了显著的关联 (p=0.04).
- 大多数参与者 (85.11%) 认定为西班牙裔或拉丁裔.
- 在教育干预和增加在识别芬太尼的信心之间没有发现显著的关联.
结论:
- 学校教育可能会增强青少年关于芬太尼暴露的行为意图,与打击过量死亡人数上升的努力保持一致.
- 该研究为了解在高强度贩毒地区的芬太尼流行病提供了有价值的背景.
- 进一步的干预是必要的,以提高青少年识别芬太尼风险的能力,尽管对行为意图的积极影响.
相关概念视频
01:23Influence of Parents and Peers on Identity
143
Adolescence is a pivotal period of identity formation, during which individuals begin to answer questions central to their sense of self, such as "Who am I?" and "Who do I hope to become?" Both parents and peers play critical roles in guiding adolescents through this complex developmental phase.
Parental Influence on Identity Development
Parents serve as primary guides and managers in an adolescent's life, offering support instrumental in decision-making and personal growth....
Parental Influence on Identity Development
Parents serve as primary guides and managers in an adolescent's life, offering support instrumental in decision-making and personal growth....
143
01:15Drug Abuse and Addiction: Pharmacological Phenomena
663
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
663
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
184
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
184
01:25Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822
02:05Self-Presentation: Self-Monitoring and Self-Handicapping
40.6K
People can go to great lengths to protect their self-image and present themselves in ways that they want others to see them. Sociologist Erving Goffman presented the idea that a person is like an actor on a stage. Calling his theory dramaturgy, Goffman believed that we use “impression management” to present ourselves to others as we hope to be perceived. Each situation is a new scene, and individuals perform different roles depending on who is present (Goffman, 1959). Think about...
40.6K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
258
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
258